Mengdan Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cervical Cancer and HPV Research
Papers in
- Oncology 6
- Co-authors
- Huihui Yu (2 shared papers)Yunyong Liu (4 shared papers)Haozhe Piao (2 shared papers)Tingting Zuo (3 shared papers)Xiaoli Cui (1 shared paper)Jing Zhang (1 shared paper)Bo Zhu (1 shared paper)Ting Sun (1 shared paper)
- Journals
- Molecules (2 papers)Preventive Medicine (1 paper)Environmental Toxicology (1 paper)Advanced Science (1 paper)Journal of Religion and Health (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Mengdan Li
23 papers receiving 298 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 71
- Epidemiology 60
- Molecular Biology 104
- Biochemistry 9
- Oncology 36
Countries citing papers authored by Mengdan Li
This map shows the geographic impact of Mengdan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdan Li more than expected).
Fields of papers citing papers by Mengdan Li
This network shows the impact of papers produced by Mengdan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdan Li. The network helps show where Mengdan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengdan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2019 | 61 | |
| 3 | 2020 | 37 | |
| 4 | 2023 | 22 | |
| 5 | 2020 | 21 | |
| 6 | 2014 | 18 | |
| 7 | 2017 | 12 | |
| 8 | 2024 | 8 | |
| 9 | 2022 | 7 | |
| 10 | 2017 | 6 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2025 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Mengdan Li
Mengdan Li is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Epidemiology, having authored 29 papers that have together received 301 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Mechanisms and Therapy (2 papers), China's Socioeconomic Reforms and Governance (2 papers), Parathyroid Disorders and Treatments (2 papers), Psychological Well-being and Life Satisfaction (1 paper), Chromium effects and bioremediation (1 paper), Media Influence and Politics (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Cancer Research (71 citations), Epidemiology (60 citations), Molecular Biology (104 citations), Biochemistry (9 citations) and Oncology (36 citations). Mengdan Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Huihui Yu, Yunyong Liu, Haozhe Piao, Tingting Zuo, Xiaoli Cui, Jing Zhang, Bo Zhu, Ting Sun, Lihong Chen and Linfeng Zhao. Their work appears in journals such as Molecules, Preventive Medicine, Environmental Toxicology, Advanced Science and Journal of Religion and Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.